Wilson disease with visceral leishmaniasis: An extremely uncommon presentation

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 3, 2007, Pages 560-561

  Pandey, K ^a   Sinha, P K ^a   Das, V N R ^a   Kumar, N ^a   Verma, N ^a   Bimal, S ^a   Lal, C S ^a   Topno, R K ^a   Singh, D ^a   Verma, R B ^a   Bhattacharya, S K ^a   Das, P ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE; PENICILLAMINE; PIPERIDINE DERIVATIVE; PYRIDOXINE; TRIPHENHEXYDYL; ZINC SULFATE; CHELATING AGENT; DRUG DERIVATIVE; PHOSPHORYLCHOLINE;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; NEUROLOGIC EXAMINATION; VISCERAL LEISHMANIASIS; WILSON DISEASE;

LEISHMANIA DONOVANI; PHLEBOTOMINAE; PHLEBOTOMUS ARGENTIPES; PROTOZOA;

ADOLESCENT; CHELATING AGENTS; HEPATOLENTICULAR DEGENERATION; HUMANS; LEISHMANIASIS, VISCERAL; MALE; PENICILLAMINE; PHOSPHORYLCHOLINE; PYRIDOXINE; ZINC SULFATE;

EID: 35748975955     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.560     Document Type: Article

References (10)

1. Desjeux P, 2000. Leishmania/ HIV Co-infection in South-Western Europe, 1990-1998, Retrospective Analysis of 965 Cases. Geneva: World Health Organization.
2. Annon, 2000. The Leishmaniasis and Leishmania/ HIV Co-In fections. Fact Sheet No. 116. Geneva: World Health Organization.
3. Davies CR, Kaye P, Croft SL, Sundar S, 2003. Leishmaniasis: new approaches to disease control. BMJ 326: 377-382.
4. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, 2002. Visceral leishmaniasis: current status of control, diagnosis and treatment, and a proposed research and development agenda. Lancet Infect Dis 2: 494-501.
5. Mak CM, Tam S, Fan ST, Lie CL, Lam CW, 2006. Wilson disease: a patient undiagnosed for 18 years. Hong Kong Med J 12: 154-158.
6. Chan P, Yang J, 2005. Gene symbol: ATP7B disease: Wilson disease. Hum Genet 118: 548.
7. Gupta A, Aikath D, Neyogi R, Datta S, Basu K, Maity B, Trivedi R, Ray J, Das SK, Gangopadhyay PK, Ray K, 2005. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet 118: 49-57.
8. Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, Junge K, Karbwang J, Bryceson AD, Berman JD, 2004. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis 138: 217-221.
9. Hoogenraad TU, 2006. Paradigm shift in treatment of Wilson disease: zinc therapy now treatment of choice. Brain Dev 28: 141-146.
10. Brewer GJ, 2006. Novel therapeutic approaches to the treatment of Wilson disease. Expert Opin Pharmacother 7: 317-324.